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Recent  studies  by  Dochez,  I,~ Malt,  3  and  Dick  and  Dick  *-e  have 
indicated  that  scarlet  fever may  be regarded  as  a  local infection  of 
the  throat  by  a  special  type  of  Streptococcus h¢molyticus which  is 
capable of producing a  soluble toxic substance.  It is supposed that 
this  toxic  substance  is  absorbed  from  the  throat  and  causes  the 
general  manifestations  of  the  disease.  Whether  this  substance 
is  a  true  exotoxin  similar  to  diphtheria  toxin  has  not  as  yet  been 
established.  It  is  supposed,  furthermore,  that  immunity  to  scarlet 
fever,  whether  existing  in  a  normal  individual  or  acquired  by  an 
attack of the disease is antitoxic in nature  and  that  the presence of 
immunity can be determined in an individual by finding out whether 
or not his serum blanches the rash in a  patient  with scarlet fever, or 
whether or not he reacts to an injection of the toxic substance found 
in filtrates  of scarlatinal  streptococcus cultures. 
The  experimental  data  on  which  the  foregoing  conception  of 
scarlet  fever is  based  may  be briefly summarized. 
i Dochez, A. R., Proc. Soc. Exp. Biol. and Med., 1923-24, xxi, 184. 
Dochez, A. R., J. Am. Med. Assn., 1924, lxxxii, 542. 
3 Mair, W., Lancet, 1923, ii, 1390. 
4 Dick, G. F., and Dick, G. H., J. Am. Med. Assn., 1923, lxxxi, 1166. 
Dick, G. F., and Dick, G. H., J. Am. Med. Assn., 1924, Ixxxii, 265. 
Dick, G. F., and Dick, G. H., J. Am. Med. Assn., 1924, lxxxii, 301. 
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Dochez and Bliss,  7 Bliss,  8,9 and  Stevens and Dochez  1° have shown that strains 
of Streptococcus hcemolyticus from the throats of patients with  scarlet fever are 
distinguishable immunologically from hemolytic streptococci from other sources 
and are themselves for the most part immunologically homologous.  These obser- 
vations have been independently substantiated by Tunnicliff  n,I2 and by GordonY 
Dochez  t'2  has  shown,  furthermore,  that  a disease resembling scarlet fever in 
many respects may be produced in guinea pigs by inoculation with  scarlatinal 
streptococci by a method which establishes a local infection in the subcutaneous 
tissue of the animal.  He has, in addition, produced an antiserum by immunization 
of a horse with living cultures of a scarlatinal streptococcus.  This antiserum has 
been shown by Blake, Trask, and Lynch  14 to possess the same properties which 
human convalescent scarlet fever serum has been shown to possess; namely, the 
ability to blanch the scarlet fever rash at the site of an intracutaneous injection 
and to exert a favorable therapeutic effect on the disease.  It is presumably anti- 
toxic in character. 
Dick and  Dick  4'6  have succeeded in producing scarlet fever in human  volun- 
teers by inoculation of scarlatinal streptococci in  the throats of the volunteers. 
They  a have shown, furthermore, that bacteria-free filtrates of cultures of scarlati- 
nal hemolytic streptococci contain a  toxic substance which produces a local reac- 
tion when injected intracutaneously in persons supposedly susceptible to scarlet 
fever.  This substance causes no reaction in persons who have had scarlet fever, 
or are supposedly immune to scarlet fever, or have been passively immunized by 
convalescent scarlet fever serum prior to the test with the toxic filtrate.  The toxic 
action of the filtrate is neutralized by in vitro incubation with convalescent scarlet 
fever serum prior to injection in a susceptible person.  Zingher  I5 has repeated and 
substantiated these observations with the toxic filtrates of scarlatinal streptococcus 
cultures and has shown that the Dick test is, in many respects, analogous to the 
Schick test for susceptibility to diphtheria. 
Mair,  ~ in a study of the Schultz-Charlton  1° blanching phenomenon, has pointed 
out that  the blanching of the scarlet fever rash by normal human  serum or by 
convalescent scarlet fever serum may be more logically interpreted as an immunity 
7 Dochez, A. R., and Bliss, W. P., J. Am. Med. Assn., 1920, lxxiv, 1600. 
s Bliss, W. P., Bull. Johns Hopkins Hasp., 1920, xxxi, 173. 
9 Bliss, W. P., J. Exp. Med., 1922, xxxvi, 575. 
~0 Stevens, F. A., and Dochez, A. R., Proc. Soc. Exp. Biol.  and Med., 1923-24, 
xxi, 39. 
11 Tunnicliff, R., J. Am. Med. Assn., 1920, lxxiv, 1386. 
12 Tunnicliff, R., J. Infect. Dis., 1922, xxxi, 373. 
i.~ Gordon, M. H., Brit. Med. J., 1921, i, 632. 
~4 Blake, F. G., Trask, J. D., Jr., and Lynch, J. F., J. Am. Med. Assn.,  1924, 
lxxxii, 712. 
15 Zingher, A., Proc. Soc. Exp. Biol. and Med., 1923-24, xxi, 293. 
10 Schultz, W., and Charlton, W., Z. Kinderheilk., 1918, xvii, 328. JAMES  D.  TRASK,  JR.,  AND  FRANCIS  G.  BLAKE  383 
reaction in which an antitoxin in the blanching serum neutralizes a toxin in the 
patient, than as a reaction due to some property of normal serum that is lost during 
the acute stage of scarlet fever as originally proposed by the discoverers of the 
phenomenon. 
In order  to provide  further evidence in support  of the  foregoing 
conception  of  scarlet  fever  an  effort  has  been  made  to  determine 
whether  a  specific  toxic  substance  could  be  demonstrated  in  the 
blood  and urine  of scarlet  fever patients during the acute  stage  of 
the disease.  The results of this study are presented in this paper. 
Methods. 
Samples  of  venous  blood  were  collected  from  patients  acutely 
ill with scarlet  fever.  After  the  blood  had  clotted,  the serum was 
separated by centrifugation, pipetted off,  and stored in the ice box 
in  sterile  bottles  without  preservative.  Specimens  of  urine  were 
filtered  through Berkefeld  filters  and  stored  in a  similar way.  All 
specimens were tested for  sterility before use.  Tests for the presence 
of a  toxic substance in the serum and urine samples were made by 
intracutaneous injections in two groups of human volunteers.  Mem- 
bers  of the first group  were  supposedly susceptible  because  it  had 
been determined that their serums failed to blanch the rash of patients 
with scarlet  fever.  Members  of the  second group were  supposedly 
insusceptible because their serums blanched the rash in patients with 
scarlet fever.  Whenever a  sample of serum or urine gave a positive 
local  reaction,  the  specificity of  the  reaction  was  controlled  by  a 
neutralization test with a  blanching serum.  This was performed by 
intracutaneous injections  in  a  known  susceptible  volunteer  of  two 
equal portions of the sample,  one of which had been mixed with a 
human serum not possessing the property of blanching the rash  of 
scarlet fever, the other of which had been mixed with a human serum 
possessing the property of blanching.  The mixtures were incubated 
in a  water bath at 37°C.  for 30  minutes prior  to injection.  A  few 
similar neutralization tests  were  also  performed with normal horse 
serum in place of the non-blanching human serum and with Dochez's 
scarlatinal antistreptococcic serum in place of the human blanching 
serum.  The  volunteer  test  subjects  were  observed  daily  and  the 
reactions  obtained  were  studied  with  respect  to  size,  duration,  in- 384  TOXIC  S~BSTANCE  IN  SCARLET  FEVER 
tensity  of  the  erythema,  presence  of  induration,  development  of 
pigmentation,  and  the  occurrence  of desquamation. 
Presence  of a  Toxic  Substance  in the  Blood  of Persons with 
Scarlet  Fever. 
For  the  preliminary  tests  specimens  of  serum  from  two  severe 
cases  of  scarlet  fever  were  selected. 
I.  Jan. 24, 1924.  Blood was collected from M. R., a highly toxic case of scarlet 
fever, on the 3rd day of the disease.  The serum, A, was separated from the clot 
and  stored in the ice box.  Feb.  16.  The 21st  day of convalescence, a  second 
sample of blood was collected, the serum, B, separated and similarly stored. 
Feb. 20, 9 a.m. 0.5 cc. of Serum A was injected intracutaneously on the flexor 
surface of the right forearm in each of three human volunteers, A. P., R. E., and 
M.B.  Control injections of 0.5 cc. of Serum B were similarly made on the left 
forearms of A. P., R. E., and M.B.  Blood serum from A. P. and R. E. had failed 
to blanch the rash of patients with scarlet fever, serum from M. B. had produced 
a well marked area of blanching.  In the supposedly susceptible volunteers, A. P. 
and R. E., Serum A produced a marked local reaction in A. P. (Fig. 1), a definite 
but less severe local reaction in R. E., whereas the control Serum B produced no 
reaction  (Fig.  2).  In  the  supposedly  insusceptible  volunteer,  M.  B.,  neither 
Serum A nor Serum B produced any reaction.  The character of the reactions is 
described in Table I. 
II. 0.3 cc. of Serum A obtained from a severe case of scarlet fever, J. M., late 
on the 5th day of the disease was injected intracutaneously in each of five human 
volunteers, two of whom were supposedly susceptible since their serums had failed 
to blanch the rash of scarlet fever, and three of whom served as supposedly insus- 
ceptible controls since their serums had produced well marked positive blanching 
tests.  Control injections of 0.3  cc.  of Serum B obtained from the same patient 
on the 2nd day of convalescence were also made in each subject.  The result was 
completely negative,  no  reaction  occurring in  any  of  the  subjects  with  either 
serum. 
In  spite  of  the  negative  result  obtained  in  the  second  test,  the 
first  one  appeared  to  be  sufficiently  definite  to  warrant  further  in- 
vestigation  of a  series  of patients  with  scarlet  fever,  especially  since 
it  seemed  possible  that  the  positive  reactions  obtained  in  the  first 
instance  might be due  to the  fact that  the blood was collected  early 
on the 3rd day of the disease,  while  the negative result in the second 
instance might be due to the fact that the blood was collected late on 
the 5th day.  At any rate, if the negative outcome of the second test ]AMES  D.  TRASK~  J'R.~  AND  FRANCIS  G.  BLAKE 
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be disregarded for the moment, the result  of the first would seem to 
show that a  toxic substance capable of producing a  well marked local 
reaction  in  the  skin  of  supposedly  susceptible  individuals,  but  no 
reaction  in  supposedly insusceptible individuals, can be demonstrated 
in the blood serum early in the course of an instance of severe scarlet 
fever. 
To provide further evidence on this point the  following procedure 
was carried  out. 
III. Single specimens of serum were obtained from 17 cases of scarlet  fever of 
varying degrees of severity; 2 were collected on the 2nd day of the disease, 9 on the 
3rd day, 5 on the 4th day, and 1 on the 5th day. 
Eight human volunteers were available for intracutaneous  tests with the scarlet 
fever serums.  Four of them,  Group A, had not had scarlet fever, and samples of 
their serums when injected intracutaneously in patients with scarlet fever failed to 
blanch  the rash.  The other four, Group B, were used as control subjects.  Two 
had had scarlet fever, two had not.  Samples of serum from all four produced  a 
well marked area of blanching  when  injected  intracutaneously in  patients  with 
scarlet fever. 
0.3 cc. of each scarlet fever serum was injected intracutaneously in one or more 
members of Group A and the resulting reactions were carefully observed.  0.3 cc. 
of each serum that gave a positive reaction  in members of Group A was injected 
similarly in one or more members of Group B. 
Six of the serums gave marked positive reactions in members of Group A, nega- 
tive reactions in members of Group B.  Five gave moderate positive reactions in 
the more susceptible members of Group A, negative reactions in members of Group 
B.  Six gave no reaction in the more susceptible  members  of Group A and were 
therefore not tested in members of Group B. 
The positive  reactions  varied from very marked reactions  showing  areas  of 
bright diffuse erythema, 50 to  70 mm. in diameter,  moderately indurated  and 
tender,  of 3 or 4 days duration,  followed by pigmentation  and desquamation,  to 
mild reactions of moderate diffuse or blotchy erythema, 20 to 30 mm. in diameter, 
not indurated or tender, of 24 to 48 hours duration,  followed by transient pigmen- 
tation and no desquamation. 
The  details  are  presented  in  Table  II. 
From the result of the foregoing test it is clear that there is a  toxic 
substance  present  in  the  blood  of  many  cases  of  scarlet  fever  in 
sufficient  concentration  to  produce  a  clear-cut  local  reaction  in the 
skin  of  normal  individuals,  provided  the  blood  serum  of  those  in- 
dividuals  gives  a  negative  Schultz-Charlton  rash  extinction  test  in JAMES  D.  TRASK,  JR.,  AND  FRANCIS  G.  BLAKE  387 
TABLE  II. 
Test for Toxic Substance in Scarlet Fever Blood by Intracutaneous  Injection in Man. 
'ohnteer test subjects. 
History of scarlet fever  ...... 
Blanching power of serum... 
Scarlet fever patients. 
Case.  Clinical severity.  ~; 
Group A.  Group B. 
0  I  0  0 
o  I  0  0 
0  0 
0  + 
d  ~.  6 
+To 
i+T+ 
1. A.  D. 
2. J.  D. 
3.  R. M.A. 
4.  C.  M. 
5.  N.  G. 
6. A.  C. 
7.  A.  Z. 
8.  L.  W. 
9.  S.  S. 
10.  H.  C. 
ll.C.P. 
12.  P.  N. 
13.  F.  E. 
14. A.  W. 
15. A.  D. 
16.  M.D. 
17.  E.  C. 
Very severe, septic. 
Mild. 
Moderately severe. 
Very toxic. 
Moderately severe. 
Very severe, septic. 
Severe, septic. 
Moderately severe. 
Mild. 
Moderately toxic. 
Mild. 
Moderately toxic. 
Mild. 
5 
3 
2 
3 
3 
4 
4 
4 
3 
3 
3 
Reaction to intracutaneous injection of 0.3 co. of 
scarlet fever serum. 
++ 
++ 
+ 
-++  - 
u 
+ +  +  indicates strongly positive reaction, 50 to 70 mm. in diameter, bright 
red, moderately indurated and tender, of 3 to 4 days duration followed by pigmen- 
tation and desquamation; + +, positive reaction, 35 to 50 ram. in diameter, bright 
red, with slight induration, of 2 to 3 days duration, followed by moderate pigmen- 
tation and occasionally slight desquamation; +, moderately positive reaction, 20 
to 35 mm. in diameter, red, no induration, of  1 to 2 days duration, with slight 
pigmentation and no desquamation; and -, no reaction. 388  TOXIC SUBSTANCE IN  SCARLET FEVER 
cases of scarlet fever.  It is furthermore evident from the variations 
in the intensity of the reactions,  that  the concentration of the toxic 
substance  varies  in  different  cases.  It  would  also  appear  by  com- 
parison of the positive reactions in Volunteers F.  G. B. and E. E. N. 
on the one hand with those in I.  H.  and E. McC.  (Table II)  on the 
other  that  individuals  vary  in  their  susceptibility.  Correlation  of 
the  positive  and  negative  reactions  with  the  day  of  the  disease  on 
which  the  serum  was  collected is  not  apparent  nor is  there  a  strict 
correlation between the  clinical  severity of  the  cases  and  the  toxic 
TABLE III. 
Neutralization of Toxic Substance in Scarlet Fever Blood by Normal Human Serum 
Possessing the  Property of  Blanching the  Rash in  Scarlet Fever. 
Reactions in Volunteer Test Subject F.G.B. 
Scarlet fever serum 
case.  Series A.  Unneutralized.  Series B.  Neutralized. 
0,3 ec. scarlet fever serum q-  0.3 cc. scarlet fever serum -b 
0.2 cc. non-blanching serum.  0.2 cc. blanching serum. 
1. A.  D. 
2. J.  D. 
3. R.M.A. 
4.  C.M. 
5. N.  G. 
6. A.  C. 
7. A.  Z. 
8. L. W. 
9.  S.  S. 
10. H.  C. 
11.  C.  P. 
Strongly positive. 
Positive. 
Moderately positive. 
Slightly positive, transient. 
Negative. 
Slightly positive, transient. 
Negative. 
Slightly positive, transient. 
Negative. 
property of the  serums.  That  the  positive reactions were  due  to  a 
toxic  substance  specifically  related  to  scarlet  fever is  indicated  by 
the  fact  that  they occurred only in members  of  Group A,  while  all 
tests  in  members  of  Group  B  were  completely  negative.  Further 
evidence in support  of this view is provided in the following test. 
Neutralization of the Toxic Substance  in the Blood of Persons with 
Scarlet Fever by Human Serum Possessing the Property 
of Blanching the Rash in Scarlet Fever. 
IV. The serums from scarlet fever patients (Nos. 1 to 11, Test III), all of which 
had given positive reactions, were used.  Series A: three parts of each serum were ~[AMES  D.  T1LASK, JR.,  AND  FP,.ANCIS  G.  BLAKE  389 
mixed with two parts of normal human serum which had been shown not to blanch 
the rash in scarlet fever.  Series B:  three parts of each serum were similarly mixed 
with two parts of normal human serum which had been shown to blanch the rash 
in scarlet fever.  Both series were incubated in a water bath at 37°C. for 30 min- 
utes.  0.5 cc. of each mixture was injected intracutaneously in an individual of 
Group A, III (Volunteer F. G. B.)  who had been shown to be susceptible to the 
toxic substance in scarlet fever serum.  As shown in Table III all the serum mix- 
tures of Series A gave positive reactions similar to those in Test III, while none of 
the serum mixtures of Series B gave positive reactions except for a faint transient 
erythema in Cases 1, 3, and 5. 
Hence  it  may  be  stated  that  the  toxic  substance  present  in  the 
blood of patients with scarlet fever is readily and completely neutra- 
lized by a  human  serum which produces a  positive Schultz-Charlton 
TABLE  IV. 
Neutralization  of Toxic Substance  in  Scarlet  Fever Blood  by Dochez's Scarlatinal 
A ntistreptococcic Serum. 
Scarlet fever serum case. 
1.  A.D. 
4.  C.M. 
5.  N. G. 
Reactions in Volunteer Test Subject I.M.W. 
Series A.  Unneutralized. 
0.3 cc. scarlet fever serum q- 
0.02 cc. normal horse serum. 
Strongly positive. 
Positive. 
Series B.  Neutralized. 
0.3 cc. scarlet fever serum -b 
0.02 cc. antisearlatinal horse serum. 
Negative. 
sg 
rash  extinction  test.  Failure  to  obtain  complete  neutralization  in 
three  of the eleven tests is not surprising when it is realized that the 
mixtures  contained  two  unknown  variables,--the  toxic  content  of 
the  scarlet fever serum and  the  anfitoxic content  of the neutralizing 
serum. 
Neutralization  Tests with Dochez's Scarlatinal Antistreptococcic  Serum. 
Since it had been found by Blake, Trask, and Lynch14 that Dochez's 
scarlatinal  antistreptococcic  serum  produces  a  marked  blanching 
of  the  rash  in  scarlet  fever  similar  to  the  Schultz-Charlton  rash 
extinction  phenomenon  produced  by  convalescent  scarlet  fever 
serum  and  by some normal human  serums, it  seemed probable that 
Dochez's serum would  neutralize  the  toxic substance in scarlet fever 390  TOXIC  SUBSTANCE  IN  SCARLET  FEVER 
blood.  After a  few preliminary trials it soon became evident  that  a 
clear-cut  result  could  be  obtained  only  in  an  individual  in  whom 
an  intracutaneous  injection  of  normal  horse  serum  produced  no 
immediate  or  accelerated local serum reaction.  Such  an  individual 
was finally found and  the  following test performed. 
v.  Volunteer  I. M.  W.;  no history of scarlet fever; serum gives a  negative 
blanching test.  Scarlet Fever Serums 1, 4, and 5 (Test III) were used.  Series A: 
three  parts  of  each serum were mixed with two parts of a 1 : 10 saline dilution of 
normal horse  serum.  Series  B : three parts of  each serum were mixed with two 
parts of a 1 : 10 saline dilution of Dochez's antiscarlatinal horse serum.  Both series 
were incubated in a water bath at 37°C. for 30 minutes.  0.5 cc. of each mixture 
was  injected  intracutaneously  in  Volunteer  I. M.W.  As  shown in Table IV 
Series A produced positive reactions, while Series B showed no reactions. 
This  test  not  only shows  that  the  toxic substance  in  scarlet  fever 
blood is  readily neutralized  by Dochez's scarlafinal antistreptococcic 
serum,  but  it  also  provides  evidence  which  supports  the  view  that 
Dochez's  serum  is  a  specific  scarlatinal  antitoxic  serum.  It  also 
suggests  that  Dochez's serum has a  relatively high antitoxic content 
since  0.02  cc.  of  the  serum  completely neutralized  0.3  cc.  of Scarlet 
Fever  Serum  1  which  was incompletely neutralized  by 0.2  cc.  of a 
human  blanching  serum  (IV). 
_Presence of  a  Toxic  Substance  in  the  Urine  of Patients  with 
Scarlet  Fever. 
Inasmuch  as  a  toxic  substance  was  readily  demonstrable  in  the 
blood of patients with scarlet fever, it seemed desirable to determine 
whether  a  similar  substance  might  be  found  in  the  urine.  Accord- 
ingly the urine  of five patients was studied  by means of intracutane- 
ous  tests  in  human  volunteers. 
Since it  was  to  be  expected  that  pseudoreactions  from other  sub- 
stances  in  the  urine  might  obscure  the  results  each  test  was  con- 
trolled by a  simultaneous  neutralization  test. 
VI.  Specimens of urine were collected from five patients with scarlet fever, fil- 
tered through Berkefeld filters, and  tested for sterility.  Parallel series of intra- 
cutaneous injections were made in  four normal volunteers,  three  of whom had 
been shown to be susceptible to the toxic substance in scarlet fever blood, and one 
of whom served as an insusceptible control.  Series A consisted of mixtures of each JAMES  D.  TRASK~  JR.,  AND  FRANCIS  G.  BLAKE  391 
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urine with normal human serum which failed to blanch the rash of patients with 
scarlet fever.  Series B  consisted  of similar mixtures of each urine with normal 
human serum which blanched the rash in scarlet fever.  The ratio of urine to serum 
in the mixtures was 1:9 except in one instance (Case N. G.) in which it was 1:1. 
Both series were incubated in a water bath at 37°C. for 30 minutes prior to injec- 
tion.  The actual amount of urine in the urine-serum mixtures injected varied from 
0.02  to 0.2 cc.  Reactions in  Series  A were considered  positive only when they 
persisted for 48 hours or more and were followed by pigmentation or desquamation 
with negative reactions in Series B and in the insusceptible control at 48 hours. 
Moderate transient erythema of about 24 hours duration occurred with nearly all 
injections and was disregarded.  As shown in Table V, two of the five cases, both 
of which  had given positive reactions with their serums, gave strongly positive 
reactions in Series A with negative reactions in the controls.  Three were negative 
in both series.  The positive reactions were characterized by bright red erythema, 
40 to 60,ram. in diameter, moderate induration and tenderness,  were of 3 to 4 days 
duration, and were followed by pigmentation and desquamation. 
The  foregoing  data  show  that  a  toxic  substance  can  be  demon- 
strated in the urine of some  cases  of  scarlet  fever.  This  substance 
is  neutralized  by  human  serum  that  blanches  the  rash  of scarlet 
fever  but  not  by  human  serum  that  fails  to  blanch  the  rash.  It 
causes  a  well  defined local reaction in  the  skin  of individuals  whose 
serums  give  a  negative  Schultz-Charlton  rash  extinction  test,  no 
reaction  in  persons  whose  serums  give  a  positive  rash  extinction 
test.  In these respects it is  similar  to  the  toxic substance  found in 
the  blood  of  scarlet  fever patients.  In  the  tests  exceedingly  small 
amounts  of  unconcentrated  urine  were  employed  in  order  to  avoid 
confusion  with  false  reactions.  It  seems  probable  that  the  toxic 
substance  specifically  related  to  scarlet  fever will  be  found  in  most 
scarlet fever urines when a  more ready method for its detection than 
that of intracutaneous  tests in human beings is devised. 
Daily  Observations  on  the  Presence  of a  Toxic  Substance  in  the 
Blood  and  Urine  of a  Patient  with Scarlet  Fever. 
The data  so far reported have dealt with single observations on a 
series of patients.  From the results obtained it has not been possible 
definitely to relate the presence or absence of the  toxic substance in 
the  blood  and  urine  with  the  course  of  the  disease.  Furthermore, 
although  there  is  in  general  a  satisfactory  agreement  between  the JAMES  D.  TRASK~  JR.,  AND  FRANCIS  G.  BLAKE  393 
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clinical  severity of a  case  and  the  presence  or  absence  of  the  toxic 
substance in  the blood and  urine,  there are  certain exceptions as in 
Cases J. M.  (II), J. D., and M. D.  (III).  It seemed desirable, there- 
fore, to make daily observations on a series of cases in order to obtain 
more  definite  information  concerning  these  points.  One  study  of 
this kind has  been completed and  may properly be included here. 
VII.  Case N. G., male; age 6.  Admitted to the hospital on the 2nd  day of 
scarlet fever, about 27 hours after onset.  Moderately severe.  Samples of blood 
and urine were collected  daily throughout the disease.  These were  tested by 
intracutaneous injections in susceptible  human volunteers, with the appropriate 
insusceptible volunteer controls and control neutralization tests.  0.3 cc. of serum 
and 0.2 cc. of urine were used in the tests.  Toxic substance was present in the 
blood from the 2nd to the 5th day, in the urine from the 3rd to the 6th day.  The 
relation of its concentration as roughly measured by the severity of the local reac- 
tions in the test subjects to the course of the disease is shown in Chart 1. 
SUMMARY. 
A  series of observations  on  the  blood  of patients  acutely ill  with 
scarlet fever has  shown  that  a  toxic substance  can be demonstrated 
in  the serum by means of intracutaneous  injections of the  serum in 
persons  who  have  not  had  scarlet  fever  and  whose  serums  fail  to 
blanch  the  rash in  scarlet  fever.  The reaction  caused  by this  sub- 
stance  consists  of a  bright  red  local  erythema,  varying from  20  to 
70 ram.  in diameter,  of  1 to 4 days duration.  The severer reactions 
are moderately indurated and tender, and are followed by pigmentation 
and  desquamation.  Control  injections  in  persons  whose  serums 
blanch  the rash in scarlet fever  cause no reaction.  The  toxic  sub- 
stance  is  not  neutralized  by  mixture  with  a  human  serum  which 
gives a  negative blanching test but is readily neutralized by a human 
serum  which  gives  a  positive  blanching  test.  It  is  not  neutralized 
by normal  horse  serum,  but  is  completely neutralized  by Dochez's 
scarlatinal  antistreptococcic  serum. 
In a  limited number of observations on the urine of patients with 
scarlet fever a  similar  toxic substance  has  been found in  two out of 
five cases studied. 
Since the  toxic substance  described appears  to resemble the  toxic 
substance found in the filtrates of scarlatinal hemolytic streptococcus JAMES D.  TRASK~ JR.,  AND  FRANCIS G.  BLAKE  395 
cultures by Dick and Dick and  since it is neutralized not only by a 
blanching  human  serum  but  also  by Dochez's  scarlatinal  antistrep- 
tococcic  horse  serum,  the  experiments  reported  support  the  con- 
ception that scarlet fever is a local infection of the throat by a particu- 
lar  type  of  Streptococcus hcemolyticus capable  of producing a  toxin 
which  is  absorbed  and  is  the  cause  of  the  general  manifestations 
of  the  disease. 
EXPLANATION OF PLATE 16. 
FIG. 1.  Volunteer A.P.  Positive local reaction on right forearm at site of intra- 
cutaneous injection of Serum A from scarlet fever case, M. R., 3rd day of disease. 
26 hours after injection. 
FIG. 2.  Volunteer A.P.  Site of control injection, left forearm, Serum B from 
scarlet fever case, M. R., 21st day of convalescence.  26 hours after injection. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL.  XL.  PLATE  16. 
FZG.  1. 
FIG.  2. 
(Trask and Blake: Toxic substance in scarlet fever.) 